BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29036304)

  • 1. IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis.
    Engelbertsen D; Rattik S; Wigren M; Vallejo J; Marinkovic G; Schiopu A; Björkbacka H; Nilsson J; Bengtsson E
    Cardiovasc Res; 2018 Jan; 114(1):180-187. PubMed ID: 29036304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content.
    Brauner S; Jiang X; Thorlacius GE; Lundberg AM; Östberg T; Yan ZQ; Kuchroo VK; Hansson GK; Wahren-Herlenius M
    Cardiovasc Res; 2018 Jan; 114(1):158-167. PubMed ID: 29016728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc17 CD8+ T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development.
    van Duijn J; de Jong MJM; Benne N; Leboux RJT; van Ooijen ME; Kruit N; Foks AC; Jiskoot W; Bot I; Kuiper J; Slütter B
    Cardiovasc Res; 2021 Dec; 117(14):2755-2766. PubMed ID: 33063097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
    Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice.
    Engelbertsen D; Depuydt MAC; Verwilligen RAF; Rattik S; Levinsohn E; Edsfeldt A; Kuperwaser F; Jarolim P; Lichtman AH
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability.
    Centa M; Jin H; Hofste L; Hellberg S; Busch A; Baumgartner R; Verzaal NJ; Lind Enoksson S; Perisic Matic L; Boddul SV; Atzler D; Li DY; Sun C; Hansson GK; Ketelhuth DFJ; Hedin U; Wermeling F; Lutgens E; Binder CJ; Maegdesfessel L; Malin SG
    Circulation; 2019 May; 139(21):2466-2482. PubMed ID: 30894016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE
    Wigren M; Rattik S; Yao Mattisson I; Tomas L; Grönberg C; Söderberg I; Alm R; Sundius L; Ljungcrantz I; Björkbacka H; Fredrikson GN; Nilsson J
    Circulation; 2019 May; 139(22):2554-2566. PubMed ID: 31136220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
    Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.
    Rattik S; Mantani PT; Yao Mattisson I; Ljungcrantz I; Sundius L; Björkbacka H; Terrinoni M; Lebens M; Holmgren J; Nilsson J; Wigren M; Nordin Fredrikson G
    Vascul Pharmacol; 2018 Dec; 111():54-61. PubMed ID: 30243560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE-/-mice.
    Gast M; Rauch BH; Nakagawa S; Haghikia A; Jasina A; Haas J; Nath N; Jensen L; Stroux A; Böhm A; Friebel J; Rauch U; Skurk C; Blankenberg S; Zeller T; Prasanth KV; Meder B; Kuss A; Landmesser U; Poller W
    Cardiovasc Res; 2019 Feb; 115(2):302-314. PubMed ID: 30101304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet.
    Burger F; Miteva K; Baptista D; Roth A; Fraga-Silva RA; Martel C; Stergiopulos N; Mach F; Brandt KJ
    Cardiovasc Res; 2021 Feb; 117(3):743-755. PubMed ID: 32219371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired macrophage trafficking and increased helper T-cell recruitment with loss of cadherin-11 in atherosclerotic immune response.
    Johnson CL; Riley L; Bersi M; Linton MF; Merryman WD
    Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H756-H769. PubMed ID: 34506228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.
    Madhur MS; Funt SA; Li L; Vinh A; Chen W; Lob HE; Iwakura Y; Blinder Y; Rahman A; Quyyumi AA; Harrison DG
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1565-72. PubMed ID: 21474820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aorta can act as a site of naïve CD4+ T-cell priming.
    MacRitchie N; Grassia G; Noonan J; Cole JE; Hughes CE; Schroeder J; Benson RA; Cochain C; Zernecke A; Guzik TJ; Garside P; Monaco C; Maffia P
    Cardiovasc Res; 2020 Feb; 116(2):306-316. PubMed ID: 30980670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.